CD8A and melanoma: Supporting this notion, purified TCR-transgenic anti-GP100 pmel CD8+ T cells (25) expanded in vitro with OMCPmutIL-2 were able to lyse B16 melanoma cells more readily than those expanded in IL-2 or IL-15 (Figure 2D).